Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples